check the last few times it had bad news it usually dips big then recovers, let's see what comes out of the meeting when they submit additional info to the fda. "The FDA is willing to restart its review with additional data and has granted Capricor Therapeutics a Type A meeting to discuss further action."
Market Data 
Markets 
AI
